Misplaced Pages

Amy Kelley

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by TJMSmith (talk | contribs) at 00:20, 13 December 2024 (start WIR). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 00:20, 13 December 2024 by TJMSmith (talk | contribs) (start WIR)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Amy Kelley
Alma materCornell University
University of California, Los Angeles
Scientific career
FieldsGeriatrics, palliative care
InstitutionsIcahn School of Medicine at Mount Sinai
National Institute on Aging

Amy S. Kelley is an American geriatrician and palliative care specialist serving as the deputy director of the National Institute on Aging since 2022. She was previously the Hermann Merkin Professor in Palliative Care at the Icahn School of Medicine at Mount Sinai.

Education

Amy S. Kelley earned a M.D. from Weill Cornell Medicine. She later completed a Master of Science in Health Services (M.S.H.S.) from the UCLA Fielding School of Public Health​​.

Career

Kelley was a professor and vice chair for health policy and faculty development at the Icahn School of Medicine at Mount Sinai. There, she held the Hermann Merkin professorship in Palliative Care within the Brookdale department of geriatrics and palliative medicine. Additionally, she served as the senior associate dean for gender equity in research affairs​​.

Her research, funded by NIH grants from the National Institute on Aging (NIA), focused on the needs of ill older adults and their families. Kelley conducted studies using data from the Health and Retirement Study (HRS) and National Health and Aging Trends Study (NHATS), often linked with Medicare claims, to analyze treatment intensity and financial burdens faced by individuals with Alzheimer's disease, related dementias, and other illnesses. Her findings emphasized the importance of identifying older adults at risk for high healthcare costs and unmet care needs​​.

In 2022, Kelley joined the NIA as deputy director, succeeding Melinda Kelley. Her responsibilities include providing strategic leadership, overseeing daily operations, and managing diversity, equity, inclusion, and accessibility (DEIA) initiatives​​. In 2024, she became the acting director of the division of neuroscience following the removal of Eliezer Masliah.

References

  1. ^ "Amy Kelley". National Institute on Aging. 2024-10-16. Retrieved 2024-12-12.Public Domain This article incorporates text from this source, which is in the public domain.
  2. ^ "Dr. Amy S. Kelley to be Honored with the 2022 Thomas and Catherine Yoshikawa Award for Outstanding Scientific Achievement in Clinical Investigation at #AGS22". American Geriatrics Society. 2022. Retrieved 2024-12-12.
  3. ^ "NIA welcomes Dr. Amy S. Kelley as deputy director". National Institute on Aging. 2022-09-12. Retrieved 2024-12-12.Public Domain This article incorporates text from this source, which is in the public domain.
  4. "Data Fabrication Ousted NIA Neuroscience Director Eliezer Masliah". Alzheimer Research Forum. 17 October 2024. Retrieved 2024-12-12.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.